← Back to headlines
EU Approves BioMarin and Amicus Merger
The European Union has given its clearance for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus.
7 Apr, 20:14 — 7 Apr, 20:14
Sources
Showing 1 of 1 sources
The European Union has given its clearance for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus.